why choose us

Clinical Trials Search

Showing 14,540 of 132,656 result(s)
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Status: Completed

Condition: Parkinson Disease

Interventions: Lenrispodun 30 mg tablets administered orally, once daily.

Date: 2023-02-24

Study of 18F-0502B PET Imaging Targeting ?-synuclein in the Diagnosis of ?-synuclein-related Diseases

Status: Completed

Condition: Positron-Emission Tomography

Interventions:

Date: 2023-02-24

Estimation of the Diaphragm Electrical Activity and Intercostal Thickening Fraction During Different Pattern of Mechanical Ventilation: PSV Versus NAVA

Status: Completed

Condition: Respiratory Failure

Interventions: intercostal thickening fraction values during PSV and NAVA modalities in patients with difficult weaning from MV admitted in ICU.

Date: 2023-02-24

Tranexamic Acid in Patients for Caesarian Delivery.

Status: COMPLETED

Condition: Postpartum Hemorrhage

Interventions: The intervention consists of administration of 1gm of Tranexamic acid (TXA) intravenously or 10-mls of placebo (normal saline) intravenously, slowly o

Date: 2023-02-24

High-dose Dual Therapy With Different Administration Frequencies

Status: Completed

Condition: Helicobacter Pylori Infection

Interventions: Proton pump inhibitor

Date: 2023-02-24

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist

Status: COMPLETED

Condition: Moderate Asthma

Interventions: The Investigator will prescribe standard of care LABA to eligible study participants.
Participants will self-administer LABA once or twice daily

Date: 2023-02-24

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

Status: Completed

Condition: Major Depressive Disorder

Interventions: The full duration of therapy will be six-weeks.
The route of administration will be oral.
The starting dose of the medication will be 10mg d

Date: 2023-02-24

A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

Status: Completed

Condition: Hypertension

Interventions: Placebo once daily for 12 weeks

Date: 2023-02-24

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Status: Completed

Condition: Hypoxia-Ischemia, Brain

Interventions: The objective of the burst suppression EEG target is to stop seizures by titrating the anesthetic infusion to suppress most of the EEG background (>

Date: 2023-02-24

Awake Axillary Impella 5.5 Placement - A Feasibility Trial

Status: NOT_YET_RECRUITING

Condition: Cardiogenic Shock

Interventions: It is an ultrasound guided brachial plexus nerve block at roots;trunks used to anesthetize the shoulder and upper arm.
Goal is to spread loc

Date: 2023-02-24